CLRO CLRO
Company Profile ↓Company Overview
CLRO (CLRO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -22.69% |
| 6 Months: | -39.77% |
| 3 Months: | +3.95% |
| 1 Month: | -73.41% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Golden Cross3d ago
- RSI (14)38.47 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 73.4% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.29M | 11.70M | 12.37M | 12.71M | 14.11M | 15.74M | 13.59M | 14.01M | 15.91M | 13.03M | 11.97M | 12.91M | 11.68M | 10.31M | 10.56M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 7.00M | 6.86M | 7.45M | 7.70M | 8.06M | 9.64M | 8.46M | 8.99M | 10.19M | 8.46M | 7.66M | 7.67M | 6.68M | 6.07M | 6.51M | 4.10M | 3.25M | 2.98M | 2.70M | 2.94M | 2.54M | 2.84M | 2.62M | 3.52M | 3.00M | 3.42M | 2.85M | 2.82M | 2.81M | 2.57M | 1.31M | 1.85M | 1.62M | 1.15M | -20.00K | -27.00K | -27.00K | -231.00K | -27.00K | -70.00K |
| Operating Income | 1.07M | 1.50M | 2.30M | 756.00K | 1.05M | 2.96M | 1.90M | 2.29M | 3.51M | 1.97M | 1.32M | 1.42M | -526.00K | -1.11M | -13.51M | -2.44M | -2.97M | -2.31M | -2.39M | -2.10M | -2.10M | -1.75M | -1.84M | -1.16M | -1.52M | -1.49M | -2.01M | -1.85M | -1.65M | -1.13M | -2.19M | -1.35M | -1.49M | -2.08M | -2.92M | -842.00K | -826.00K | -4.56M | -854.00K | -850.00K |
| Net Income | 731.00K | 1.04M | 1.66M | 485.00K | 882.00K | 1.59M | 1.27M | 1.51M | 2.42M | 1.37M | 955.00K | 1.21M | -468.00K | -820.00K | -9.28M | -1.85M | -2.16M | -10.14M | -2.35M | -2.10M | -1.98M | -1.85M | -1.94M | -1.26M | -1.66M | -1.59M | -2.17M | -1.97M | -257.00K | -1.25M | -832.00K | -1.02M | -1.35M | -1.90M | -2.82M | -2.06M | -2.83M | -4.57M | -13.74M | -487.00K |
| Diluted EPS | 0.08 | 0.11 | 0.18 | 0.05 | 0.09 | 0.17 | 0.13 | 0.16 | 0.25 | 0.14 | 0.10 | 0.13 | -0.05 | -0.09 | -1.09 | -0.22 | -0.26 | -1.22 | -0.14 | -0.13 | -0.12 | -0.11 | -0.12 | -0.07 | -0.09 | -0.08 | -0.11 | -0.08 | -0.01 | -0.05 | -0.03 | -0.04 | -0.06 | -0.08 | -1.76 | -1.29 | -1.71 | -2.64 | -7.92 | -0.18 |
| R&D Expense | 1.87M | 1.84M | 1.79M | 2.24M | 2.33M | 2.31M | 1.94M | 2.05M | 2.13M | 2.27M | 2.10M | 2.12M | 2.36M | 2.32M | 2.27M | 2.06M | 1.92M | 1.78M | 1.59M | 1.31M | 1.43M | 1.34M | 1.47M | 1.50M | 1.27M | 1.49M | 1.49M | 1.35M | 1.18M | 876.00K | 1.04M | 873.00K | 889.00K | 894.00K | 868.00K | 0 | 0 | 1.36M | 0 | 0 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.28M | 46.07M | 46.42M | 49.59M | 57.91M | 57.80M | 48.64M | 41.80M | 28.16M | 25.04M | 29.07M | 28.97M | 25.20M | 18.70M | 0 | 0 |
| Gross Profit | 24.64M | 27.55M | 27.33M | 29.86M | 35.32M | 36.72M | 29.49M | 24.01M | 13.37M | 11.19M | 12.56M | 11.92M | 9.46M | 6.36M | -194.00K | -328.00K |
| Operating Income | 1.80M | 10.57M | 42.52M | 7.62M | 7.97M | 10.26M | 3.57M | -16.19M | -10.33M | -8.56M | -5.57M | -7.50M | -7.22M | -6.77M | -2.13M | -4.40M |
| Net Income | 2.37M | 6.93M | 26.65M | 5.18M | 5.60M | 6.78M | 2.44M | -14.17M | -16.69M | -8.41M | 505.00K | -7.69M | 20.56M | -560.00K | -8.98M | -26.08M |
| Diluted EPS | 0.27 | 0.75 | 2.89 | 0.55 | 0.58 | 0.71 | 0.26 | -1.65 | -1.87 | -0.51 | 0.03 | -0.39 | 0.83 | -0.02 | -5.61 | -14.77 |
| R&D Expense | 7.74M | 7.13M | 8.26M | 7.56M | 8.97M | 8.32M | 8.58M | 9.34M | 7.84M | 5.78M | 5.51M | 5.79M | 4.39M | 3.67M | 3.30M | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 43.98M | 49.56M | 91.94M | 81.06M | 88.86M | 93.53M | 88.12M | 67.88M | 58.91M | 55.11M | 62.32M | 66.19M | 83.75M | 50.69M | 26.54M | 2.30M |
| Total Equity | 29.10M | 31.73M | 39.66M | 66.67M | 70.33M | 76.02M | 82.57M | 77.45M | 56.57M | 52.20M | 44.48M | 49.81M | 51.50M | 74.13M | 44.69M | 21.33M | -714.00K |
| Cash & Equivalents | 9.49M | 11.43M | 16.68M | 55.51M | 17.19M | 7.44M | 13.41M | 12.10M | 5.57M | 11.21M | 4.06M | 3.80M | 1.07M | 984.00K | 17.84M | 1.42M | 220.00K |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | 2.22M | 3.25M | 1.53M | 0 | 0 | - | - |
| Total Liabilities | - | 12.25M | 9.89M | 25.27M | 10.73M | 12.84M | 10.96M | 10.68M | 11.31M | 6.71M | 10.63M | 12.51M | 14.69M | 9.62M | 6.01M | 5.21M | 3.01M |
| Current Liabilities | - | 11.24M | 8.75M | 22.82M | 8.65M | 10.76M | 9.61M | 9.32M | 10.60M | 6.01M | 6.25M | 7.10M | 11.47M | 8.12M | 4.26M | 3.54M | 1.49M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.39M | 5.80M | 43.92M | -9.95M | 6.71M | 7.59M | 7.83M | -9.27M | -6.62M | -4.66M | -982.00K | -4.39M | -4.18M | 54.63M | -6.12M | - |
| Investing Cash Flow | -449.00K | -1.36M | -5.21M | -26.54M | -14.42M | -648.00K | -922.00K | 10.19M | 3.15M | -5.13M | -5.54M | -8.51M | 2.08M | -4.88M | 4.19M | - |
| Financing Cash Flow | -2.00M | 813.00K | 108.00K | -1.82M | -2.02M | -913.00K | -8.19M | -7.51M | 9.19M | 2.68M | 6.28M | 10.21M | 2.05M | -32.89M | -14.47M | - |
| Capital Expenditure | 799.00K | -380.00K | -574.00K | -1.04M | -642.00K | -359.00K | -730.00K | -638.00K | -336.00K | -205.00K | -284.00K | -221.00K | -51.00K | -375.00K | -196.00K | - |
| Free Cash Flow | 5.18M | 5.42M | 43.35M | -10.99M | 6.07M | 7.24M | 7.10M | -9.91M | -6.96M | -4.86M | -1.27M | -4.62M | -4.23M | 54.25M | -6.31M | - |
| Share Buybacks | - | 0 | 384.00K | 2.42M | 2.60M | 0 | 6.09M | 5.12M | 147.00K | - | - | - | - | - | - | - |
| Dividends Paid | - | - | - | 0 | 914.00K | 1.42M | 1.82M | 2.24M | 583.00K | - | - | - | 0 | 28.98M | 14.50M | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 59.7% | 59.8% | 58.9% | 60.2% | 61.0% | 63.5% | 60.6% | 57.4% | 47.5% | 44.7% | 43.2% | 41.1% | 37.5% | 34.0% | - | - |
| Operating Margin % | 4.4% | 22.9% | 91.6% | 15.4% | 13.8% | 17.8% | 7.3% | -38.7% | -36.7% | -34.2% | -19.2% | -25.9% | -28.7% | -36.2% | - | - |
| Net Margin % | 5.8% | 15.0% | 57.4% | 10.4% | 9.7% | 11.7% | 5.0% | -33.9% | -59.3% | -33.6% | 1.7% | -26.6% | 81.6% | -3.0% | - | - |
| ROE % | 7.5% | 17.5% | 40.0% | 7.4% | 7.4% | 8.2% | 3.2% | -25.1% | -32.0% | -18.9% | 1.0% | -14.9% | 27.7% | -1.3% | -42.1% | 3,653.2% |
| ROCE % | 5.5% | 25.9% | 61.5% | 10.5% | 10.2% | 12.2% | 4.5% | -28.3% | -19.5% | -17.5% | -10.1% | -13.7% | -9.5% | -14.6% | -9.3% | -541.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CLRO
ClearOne bets on sight-restoring neurostimulation with Cortigent merger - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVnFUS1QyR3BmNVNON3duOFpVcEw2OHpWTVRxNzdZcWZYeFdtM2hyeVh1MnpMZ3U4c1M0TE8tZF80WmdOQnVkWkR1dGE5d196VkZsdGNHbkJJYi1vdmU2Nk5fV1hPWTdnTzRWVzdaOU1IejhqLTVzdHRCVTcwQjF6M2JHeWt3Smh6TEJPeW…
ClearOne (CLRO) Soars As Cortigent Merger Transforms The Story - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9vSklHMTNDUFB0QTNHOGF3MWRUcWhVUlhUUVRaN3dHYXJBNEFXbUlib21BNUhTb3pnZTJsQmRrM0pmSVZGRVBmdmpqTVJERl9VOXFHckp3aHB2VUVkVk5wLXk2dnYxM2p1Z01qSGdCZE1RSE0?oc=5" target="_blank">ClearOne (CL…
Why Did CLRO Stock Surge More Than 170% Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPSGZDN1ZuMVFDX3V0anRuOXY5a2hwWU5aUF96WlFvVHJ3bXhLUE4wVzBkcFE1aF8tQUNid3gwcGhZSUJ4RFJwbmVIQ3Rza2NkTmpnUk9XY3ZtWmtaOVlnR3ZyX3Z6ZE5DY1h0X3UxVXJNS21acE56UDRxUlNKQ2w4MkZXcm5HcEE5TU9rOU…
ClearOne Stock (CLRO) Opinions on Major Shareholder Purchase - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOdHZnWDZ3R1MxUlVRcV9YTm5LbDI2V0pPTWl6UjlwbzRQQVQwUTlxSFppZDBhZE5aUUFCcDF2cnZZUmN6NFpzWmZ3V2FKV2phWWNKS1A2aWtQUGlKaTRBcE5vb0pCMFY3aGN3NzhiQ3FvWUFkdFhxc01Eb0dUR2JXUVYyeHZsdlpQTGdfWn…
ClearOne, Inc.'s (NASDAQ:CLRO) Share Price Boosted 32% But Its Business Prospects Need A Lift Too - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeEllT2FtYTMtTzdIR3RaUEt4QXBldU5HVzlOQk5PVXZWWlZ1cGZMWnE2ZHVYb0pkN1lHQmpMdGhFd1R2MURRZDJwalhKa1AzbkNRM2xsVkhSX2JhdURoRGlEVVNGcXF2SS0wMmY1a01QQmxLNnRuVThUVE1wNDB5WnQyUEV4bDFvMGJpVV…
CLRO|Clearone Inc|Price:4.386|Chg%:+0.306 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5ya1ZlN1BRTFRUa2F6ZnZER2xxVWhZLUdtOFZBUGU2ZVJjTnRHTHJWTkJWNXFyVWZkRVlhSHhRN2hSb3cyc1lvSXVFbmQ2MmVFaGtOeDFDWHI3WVl3THZWUEpyTHlORUNTZ21XMVBR?oc=5" target="_blank">CLRO|Clearone Inc|P…
CLRO — Frequently Asked Questions
What is the current share price of CLRO?
As of 2026-08-05 17:25 PDT, CLRO trades at $3.68 on NASDAQ/NYSE. Its 52-week range is $2.72 to $13.84.
What is the P/E ratio of CLRO?
CLRO trades at a trailing price-to-earnings (P/E) ratio of -0.25.
Is CLRO a good stock to buy?
This page provides a data-driven analysis of CLRO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.